Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 18
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of Genetic Loci Associated With Intracerebral Hemorrhage Using a Multitrait Analysis Approach

  • Muiño, Elena|||0000-0001-5839-7328
  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Cullell, Natalia|||0000-0001-5118-1014
  • Lledós, Miquel|||0000-0001-8832-789X
  • Martín-Campos, Jesús María|||0000-0003-0414-037X
  • Villatoro-González, Paula|||0009-0001-0287-4073
  • Sierra-Marcos, Alba|||0000-0001-6570-9318
  • Ros-Castelló, Victoria|||0000-0002-9523-3012
  • Aguilera-Simón, Ana|||0000-0003-1428-8212
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
Background and Objectives Genome-wide association studies (GWASs) have only 2 loci associated with spontaneous intracerebral hemorrhage (ICH): APOE for lobar and 1q22 for nonlobar ICH. We aimed to discover new loci through an analysis that combines correlated traits (multi-trait analysis of GWAS [MTAG]) and explore a gene-based analysis, transcriptome-wide association study (TWAS), and proteome-wide association study (PWAS) to understand the biological mechanisms of spontaneous ICH providing potential therapeutic targets. Methods We use the published MTAG of ICH (patients with spontaneous intraparenchymal bleeding) and small-vessel ischemic stroke. For all ICH, lobar ICH, and nonlobar ICH, a pairwise MTAG combined ICH with traits related to cardiovascular risk factors, cerebrovascular diseases, or Alzheimer disease (AD). For the analysis, we assembled those traits with a genetic correlation ≥0.3. A new MTAG combining multiple traits was performed with those traits whose pairwise MTAG yielded new GWAS-significant single nucleotide polymorphisms (SNPs), with a posterior-probability of model 3 (GWAS-pairwise) ≥0.6. We perform TWAS and PWAS that correlate the genetic component of expression or protein levels with the genetic component of a trait. We use the ICH cohort from UK Biobank as replication. Results For all ICH (1,543 ICH, 1,711 controls), the mean age was 72 ± 2 in cases and 70 ± 2 in controls, and half of them were women. Replication cohort: 700 ICH and 399,717 controls. Novel loci were found only for all ICH (the trait containing lobar and nonlobar ICH), combining data of ICH and small vessel stroke, white matter hyperintensities volume, fractional anisotropy, mean diffusivity, and AD. We replicated 6 SNPs belonging to 2q33.2 (ICA1L, β = 0.20, SE = 0.03, p value = 8.91 × 10), 10q24.33 (OBFC1, β = -0.12, SE = 0.02, p value = 1.67 × 10), 13q34 (COL4A2, β = 0.02, SE = 0.02, p value = 2.34 × 10), and 19q13.32 (APOC1, β = -0.19, SE = 0.03, p value = 1.38 × 10; APOE, β = 0.21, SE = 0.03, p value = 2.70 × 10; PVRL2:CTB-129P6.4, β = 0.15, SE = 0.03, p value = 1.38 × 10); 2 genes (SH3PXD2A, Z-score = 4.83, p value = 6.67 × 10; and APOC1, Z-score: = 5.11, p value = 1.60 × 10); and ICA1L transcript (Z-score = 6.8, p value = 9.1 × 10) and protein levels (Z-score = -5.8, p value = 6.7 × 10).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Antibody responses to common viruses according to COVID-19 severity and postacute sequelae of COVID-19

  • Karachaliou, Marianna|||0000-0002-3014-0747
  • Ranzani, Otavio|||0000-0002-4677-6862
  • Espinosa, Ana|||0000-0001-7399-3267
  • Iraola-Guzmán, Susana|||0000-0003-3359-1241
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Vidal, M.
  • Jiménez, A.
  • Bañuls, Marc
  • Nogués, E.A.
  • Aguilar, R.
  • Garcia-Aymerich, Judith|||0000-0002-7097-4586
  • de Cid, Rafael|||0000-0003-3579-6777
  • Dobaño, C.
  • Moncunill, G.
  • Kogevinas, Manolis|||0000-0002-9605-0461
Limited research suggests that certain viruses reactivate in severe-acute-respiratory-syndrome-coronavirus 2 infection, contributing to the development of postacute sequelae of COVID-19 (PASC). We examined 1083 infected individuals from a population-based cohort, and assessed differences in plasma immunoglobulin (Ig)G and immunoglobulin A levels against Epstein-Barr virus (EBV), cytomegalovirus, varicella zoster virus (VZV), BK polyomavirus, KI polyomavirus, WU polyomavirus (WUPyV), respiratory syncytial virus, and Adv-36 according to the severity of previous COVID-19 and PASC history. Individuals who had experienced severe COVID-19 had higher antibody responses to latent viruses. Ever PASC, active persistent PASC, and PASC with neuropsychiatric symptoms were associated with higher immnoglobulin G to EBV early antigen-diffuse, VZV, and WUPyV even among individuals without previous severe COVID-19.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomab

  • Jabbour, E.J.|||0000-0003-4465-6119
  • Kantarjian, Hagop M.|||0000-0002-1908-3307
  • Goekbuget, N.
  • Shah, B.D.
  • Chiaretti, S.
  • Park, J.H.|||0000-0002-2903-5130
  • Rijneveld, A.W.
  • Gore, L.
  • Fleming, S.
  • Logan, A.C.
  • Ribera, Jose-Maria|||0000-0003-1042-6024
  • Menne, T.F.
  • Mezzi, K.
  • Zaman, F.
  • Velasco, K.
  • Boissel, Nicolas|||0000-0003-2091-7927
This narrative review seeks to summarize chemotherapeutic regimens commonly used for patients with newly diagnosed Philadelphia (Ph) chromosome-negative B-cell precursor acute lymphoblastic leukemia (BCP-ALL) in the frontline setting and to describe the latest clinical research using the bispecific T-cell-engaging immunotherapy blinatumomab in the first-line treatment setting. Current standard-of-care chemotherapeutic backbones for newly diagnosed Ph-negative BCP-ALL are based on the same overarching treatment principle: to reduce disease burden to undetectable levels and maintain lasting remission. The adult treatment landscape has progressively evolved following the adoption of pediatric-inspired regimens. However, these intense regimens are not tolerated by all, and high-risk patients still have inferior outcomes. Therefore, designing more effective and less toxic strategies remains key to further improving efficacy and safety outcomes. Overall, the treatment landscape is evolving in the frontline, and integration of blinatumomab into different standard frontline regimens may improve overall outcomes with a favorable safety profile.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

  • Maxwell, Christopher|||0000-0002-0713-7136
  • Benítez, Javier J.
  • Gómez-Baldó, Laia
  • Osorio, Ana|||0000-0001-8124-3984
  • Bonifaci, Núria|||0000-0002-8193-6825
  • Fernández-Ramires, Ricardo|||0000-0002-6974-2593
  • Costes, Sylvain|||0000-0002-8542-2389
  • Guinó, Elisabet|||0000-0003-0093-2652
  • Chen, Helen
  • Evans, Gareth|||0000-0002-8482-5784
  • Mohan, Pooja
  • Català, Isabel
  • Petit Montserrat, Anna|||0000-0002-9284-095X
  • Aguilar, Helena
  • Villanueva, Alejandro|||0000-0001-5164-0006
  • Aytes, Alvaro|||0000-0003-0725-5340
  • Serra-Musach, Jordi
  • Rennert, Gad|||0000-0002-8512-068X
  • Lejbkowicz, Flavio|||0000-0001-5718-0418
  • Peterlongo, Paolo|||0000-0001-6951-6855
  • Manoukian, Siranoush
  • Peissel, Bernard|||0000-0001-9233-3571
  • Ripamonti, Carla Barbara|||0000-0002-2892-8164
  • Bonanni, Bernardo|||0000-0003-3589-2128
  • Viel, Alessandra|||0000-0003-2804-0840
  • Allavena, Anna
  • Bernard, Loris
  • Radice, Paolo|||0000-0001-6298-4111
  • Friedman, Eitan|||0000-0002-6745-1733
  • Kaufman, Bella
  • Laitman, Yael
  • Dubrovsky, Maya
  • Milgrom, Roni
  • Jakubowska, Anna|||0000-0002-5650-0501
  • Cybulski, Cezary|||0000-0002-2819-3057
  • Gorski, Bohdan
  • Jaworska, Katarzyna
  • Durda, Katarzyna
  • Sukiennicki, Grzegorz
  • Lubinski, Jan|||0000-0003-2931-3003
  • Shugart, Yin Yao
  • Domchek, Susan M.|||0000-0002-5914-7272
  • Letrero, Richard
  • Weber, Barbara L.
  • Hogervorst, Frans B. L.
  • Rookus, Matti A.
  • Collee, J. Magriet
  • Devilee, Peter|||0000-0002-8023-2009
  • Ligtenberg, Marjolijn J.
  • van der Luijt, Rob|||0000-0002-0018-1089
  • Aalfs, Cora M.
  • Waisfisz, Quinten|||0000-0002-7384-9182
  • Wijnen, Juul
  • van Roozendaal, Cornelis E. P.
  • HEBON, None
  • EMBRACE, None
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Peock, Susan
  • Cook, Margaret
  • Oliver, Clare
  • Frost, Debra
  • Harrington, Patricia
  • Lalloo, Fiona
  • Eeles, Rosalind|||0000-0002-3698-6241
  • Izatt, Louise|||0000-0003-1258-4843
  • Chu, Carol
  • Eccles, Diana M.|||0000-0002-9935-3169
  • Douglas, Fiona
  • Brewer, Carole
  • Nevanlinna, Heli|||0000-0002-0916-2976
  • Heikkinen, Tuomas|||0000-0003-1154-6204
  • Couch, Fergus J.
  • Wang, Xianshu
  • Lindor, Noralane M.
  • Godwin, Andrew K.|||0000-0002-3987-9580
  • Caligo, Maria|||0000-0003-0589-1829
  • Lombardi, Grazia
  • Loman, Niklas
  • Karlsson, Per
  • Ehrencrona, Hans|||0000-0002-5589-3622
  • von Wachenfeldt, Anna
  • SWE-BRCA, None
  • Barkardottir, Rosa
  • Hamann, Ute|||0000-0001-6705-7624
  • Rashid, Muhammad U.|||0000-0002-7684-3122
  • Lasa, Adriana|||0000-0001-9957-9646
  • Caldes, Trinidad
  • Andrés Conejero, Raquel
  • Schmitt, Michael
  • Assmann, Volker
  • Stevens, Kristen
  • Offit, Kenneth
  • Curado, João
  • Tilgner, Hagen U.|||0000-0002-7058-3606
  • Guigó, Roderic|||0000-0002-5738-4477
  • Aiza, Gemma|||0000-0001-8654-3724
  • Brunet, Joan|||0000-0003-1945-3512
  • Castellsagué, Joan|||0000-0002-2579-3137
  • Martrat, Griselda
  • Urruticoechea, Ander|||0000-0003-0359-3641
  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Tihomirova, L.
  • Goldgar, D. E.
  • Buys, S.
  • John, Esther M.
  • Miron, A.
  • Southey, M.
  • Daly, M.B.
  • BCFR, None
  • Schmutzler, R.K.
  • Wappenschmidt, B.
  • Meindl, A.
  • Arnold, N.
  • Deissler, H.
  • Varon-Mateeva, Raymonda
  • Sutter, C.
  • Niederacher, D.
  • Imyamitov, E.
  • Sinilnikova, O.M.
  • Stoppa-Lyonne, D.
  • Mazoyer, S.
  • Verny-Pierre, C.
  • Castera, L.
  • de Pauw, A.
  • Bignon, Y.J.
  • Uhrhammer, N.
  • Peyrat, J.P.
  • Vennin, P.
  • Ferrer, S.
  • Collonge-Rame, M.A.
  • Mortemousque, I.
  • GEMO Study Collaborators, None
  • Spurdle, A.B.
  • Beesley, J.
  • Chen, X.
  • Healey, S.
  • Barcellos-Hoff, M.H.
  • Gruber, S.B.
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Capella, Gabriel|||0000-0002-4669-7320
  • McGuffog, L.
  • Antoniou, A.C.
  • Chenevix-Trench, G.
  • Fleisch, M.C.
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Pujana, Miguel Angel|||0000-0003-3222-4044
Differentiated mammary epithelium shows apicobasal polarity, and loss of tissue organization is an early hallmark of breast carcinogenesis. In BRCA1 mutation carriers, accumulation of stem and progenitor cells in normal breast tissue and increased risk of developing tumors of basal-like type suggest that BRCA1 regulates stem/progenitor cell proliferation and differentiation. However, the function of BRCA1 in this process and its link to carcinogenesis remain unknown. Here we depict a molecular mechanism involving BRCA1 and RHAMM that regulates apicobasal polarity and, when perturbed, may increase risk of breast cancer. Starting from complementary genetic analyses across families and populations, we identified common genetic variation at the low-penetrance susceptibility HMMR locus (encoding for RHAMM) that modifies breast cancer risk among BRCA1, but probably not BRCA2, mutation carriers: n = 7,584, weighted hazard ratio (<inf.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands

  • Díaz-Tejedor, A.
  • Rodríguez-Ubreva, Javier|||0000-0003-4707-4536
  • Ciudad, Laura|||0000-0002-5219-6792
  • Lorenzo-Mohamed, M.
  • González-Rodríguez, M.
  • Castellanos, B.
  • Sotolongo-Ravelo, J.
  • San-Segundo, L.
  • Corchete, L.A.
  • González-Méndez, L.
  • Martín Sánchez, Montserrat
  • Mateos, M. V.|||0000-0003-2390-1218
  • Ocio, Enrique M.|||0000-0002-5765-0085
  • Garayoa, M.
  • Paíno, T.
Multiple myeloma is a malignancy characterized by the accumulation of malignant plasma cells in bone marrow and the production of monoclonal immunoglobulin. A hallmark of cancer is the evasion of immune surveillance. Histone deacetylase inhibitors have been shown to promote the expression of silenced molecules and hold potential to increase the anti-MM efficacy of immunotherapy. The aim of the present work was to assess the potential effect of tinostamustine (EDO-S101), a first-in-class alkylating deacetylase inhibitor, in combination with daratumumab, an anti-CD38 monoclonal antibody (mAb), through different preclinical studies. Tinostamustine increases CD38 expression in myeloma cell lines, an effect that occurs in parallel with an increment in CD38 histone H3 acetylation levels. Also, the expression of MICA and MICB, ligands for the NK cell activating receptor NKG2D, augments after tinostamustine treatment in myeloma cell lines and primary myeloma cells. Pretreatment of myeloma cell lines with tinostamustine increased the sensitivity of these cells to daratumumab through its different cytotoxic mechanisms, and the combination of these two drugs showed a higher anti-myeloma effect than individual treatments in ex vivo cultures of myeloma patients' samples. In vivo data confirmed that tinostamustine pretreatment followed by daratumumab administration significantly delayed tumor growth and improved the survival of mice compared to individual treatments. In summary, our results suggest that tinostamustine could be a potential candidate to improve the efficacy of anti-CD38 mAbs.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Short-term exposure to desert dust and sandstorms and all-cause and cause-specific mortality and morbidity, A systematic review and meta-analysis

  • Tobías, A.
  • Querol Carceller, Xavier|||0000-0002-6549-9899
  • Roqué i Figuls, Marta|||0000-0003-0043-1364
  • Suu Lwin, K.
  • Yuan, L.
  • Ith, Sophearen
  • Zin Wai, H.
  • Lester Chua, P.
  • Solá, I.
  • Renzi, M.
  • Stafoggia, M.
  • Hashizume, M.
Background: Desert dust and sandstorms raise concerns about their adverse effects on human health. Over the last decade, special attention has been given to mineral dust particles from desert sand. However, evidence from previous literature reviews has yielded inconclusive results regarding their health effects. We aim to systematically synthesize evidence on the short-term health effects of desert dust exposure from major dust source areas. Methods: The bibliographic search was conducted using the MEDLINE (PubMed), Scopus, and Web of Science databases to investigate the health effects of short-term exposure to desert dust in human populations, using time series or case-crossover study designs. Study selection and reporting followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We evaluated the risk of bias (RoB) for individual studies and the certainty of evidence (CoE) for environmental exposures, as developed by a group of experts convened by the World Health Organization (WHO). Publication bias was examined using funnel plots and Begg's asymmetry test. Results: A total of 71 studies were included in the review, covering data from 1993 to 2024. Most studies focused on Asian and African desert dust, with fewer studies from Arabian, American, and Australian regions. We found a significant increase in the risk for all-cause mortality (Relative Risk, RR = 1.0121, 95 %CI = [1.0045, 1.0199]). In addition, the mortality risk associated with particulate matter less than 10 μm (PM10) was slightly higher on dust days compared to non-dust days, while for particulate matter less than 2.5 μm (PM2.5), the risk was higher on non-dust days. We also observed a significant increase in the risk for cardiovascular mortality (RR = 1.0252, 95 % CI = [1.0100, 1.0407]) during dust days compared to non-dust days, but not for respiratory mortality (RR = 1.0001, 95 % CI = [0.9773, 1.0277]). The risk also increased for cardiovascular (RR = 1.0094, 95 % CI = [1.0014, 1.0174]) and respiratory morbidity (RR = 1.0693, 95 % CI = [1.0188, 1.1224]). Conclusion: Exposure to desert dust and sandstorms is linked to increased risks of all-cause and cardiovascular mortality, as well as respiratory morbidity. The overall evidence quality for each exposure-outcome combination was assessed as moderate, although data limitations prevent the establishment of specific air quality thresholds for desert dust particles. This review highlights the need for targeted public health interventions in affected regions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Toluene early morning peaks as potential biogenic stress signals of Mediterranean forests

  • Yáñez Serrano, Ana María|||0000-0001-6408-5961
  • Lampadariou, Mirto
  • Filella, Iolanda|||0000-0001-6262-5733
  • Llusia, Joan|||0000-0003-0164-2737
  • Seco, Roger|||0000-0002-2078-9956
  • Fernández-Martínez, Marcos|||0000-0002-5661-3610
  • Portillo-Estrada, Miguel|||0000-0002-0348-7446
  • Mihalopoulos, Nikolaos|||0000-0002-1282-0896
  • Massagué, Jordi|||0000-0003-0099-2014
  • Perez, Noemi|||0000-0003-2420-6727
  • Savadkoohi, Marjan|||0000-0002-3707-2601
  • Pandolfi, Marco|||0000-0002-7493-7213
  • Peñuelas, Josep|||0000-0002-7215-0150
  • Querol Carceller, Xavier|||0000-0002-6549-9899
  • Alastuey, Andrés|||0000-0002-5453-5495
Mediterranean forests emit biogenic volatile organic compounds (BVOCs) that significantly influence atmospheric chemistry and ecosystem functioning. Due to high solar radiation and the important anthropogenic emission of atmospheric pollutants in the Western Mediterranean Basin, photochemical activity is enhanced, favouring the formation of ozone and secondary organic aerosols. We measured ambient mixing ratios of volatile organic compounds (VOCs) using Proton Transfer Reaction Mass Spectrometry (PTR-MS) at Montseny Natural Park, a Mediterranean forest 60 km from Barcelona, during summers 2021–2023. Surprisingly, during heat wave conditions, a toluene early morning peak of 0.23 (interquartile range 0.18) ppbv was observed. These early morning peaks were associated with prolonged high temperatures (approximately 5 °C higher as compared to non-peak days) and persistently higher vapour pressure deficit (approximately 877 Pa higher as compared to non-peak days), suggesting a potential link to vegetation drought stress. Cross-validation of measurements with Gas Chromatography-Mass Spectrometry (GC-MS) enhanced data reliability. Analysis of the meteorology and the variability of other atmospheric pollutants at the site, allowed to attribute these peaks to a local biogenic origin. These findings suggest that early morning toluene peaks could serve as an indicator of Mediterranean forest vulnerability to climate-induced stressors, with potentially more frequent and intense peaks occurring in the future.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

ReMindCare, an app for daily clinical practice in patients with first episode psychosis: A pragmatic real-world study protocol

  • Bonet, Lucía
  • Torous, John
  • Sanjuán, Julio
  • Arce Grilo, Alexandre David|||0000-0003-1141-2126
  • Blanquer Espert, Ignacio|||0000-0003-1692-8922
[EN] Aim Despite the potential benefits of e-health interventions for patients with psychosis, the integration of these applications into the clinical workflow and analysis of their long-term effects still face significant challenges. To address these issues, we developed the ReMindCare app. This app aims to improve the treatment quality for patients with psychosis. We chose to study the app in real world and pragmatic manner to ensure results will be generalizable. Methods This is a naturalistic empirical study of patients in a first episode of psychosis programme. The app was purpose-designed based on two previous studies, and it offers the following assessments: (a) three daily questions regarding anxiety, sadness and irritability; and (b) 18 weekly questions about medication adherence, medication side effects, medication attitudes and prodromal symptoms. The app offers preset alerts, reminders and the ability for patients to reach out to their clinicians. Data captured by the app are linked to the electronic medical record of the patient. Patients will use the app as part of their ongoing care for a maximum period of 5 years, and assessments will occur at baseline and at the end of the first, second and fifth years of app use. Results Recruitment started in October 2018 and is still ongoing. Conclusions The ReMindCare app represents early real-world use of digital mental health tools that offer direct integration into clinical care. High retention and compliance rates are expected, and this will in turn lead to improved quality of assessments and communication between patients and clinicians., Centro de Investigacion Biomedica en Red de Salud Mental; European Social Fund, Grant/Award Number: 2017/9830; Generalitat Valenciana, Grant/Award Number: PROMETEO/2016/082; Instituto de Salud Carlos III, Grant/Award Numbers: PI01399, PI13/00447, PI17/00402
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

ReMindCare App for Early Psychosis: Pragmatic Real World Intervention and Usability Study

  • Bonet, Lucía
  • Torous, John
  • Sanjuan, Julio
  • Arce Grilo, Alexandre David|||0000-0003-1141-2126
  • Blanquer Espert, Ignacio|||0000-0003-1692-8922
[EN] Background: eHealth interventions are widely used in clinical trials and increasingly in care settings as well; however, their efficacy in real-world contexts remains unknown. ReMindCare is a smartphone app that has been systematically implemented in a first episode of psychosis program (FEPP) for patients with early psychosis since 2018. Objective: The objective of this study was to assess the efficacy of ReMindCare after 19 months of use in the clinic and varying use by individual patients. Methods: The integration of the ReMindCare app into the FEPP started in October 2018. Patients with early psychosis self-selected to the app (ReMindCare group) or treatment as usual (TAU group). The outcome variables considered were adherence to the intervention and number of relapses, hospital admissions, and visits to urgent care units. Data from 90 patients with early psychosis were analyzed: 59 in the ReMindCare group and 31 in the TAU group. The mean age of the sample was 32.8 (SD 9.4) years, 73% (66/90) were males, 91% (83/90) were White, and 81% (74/90) were single. Results: Significant differences between the ReMindCare and TAU groups were found in the number of relapses, hospitalizations, and visits to urgent care units, with each showing benefits for the app. Only 20% (12/59) of patients from the ReMindCare group had a relapse, while 58% (18/31) of the TAU patients had one or more relapses (chi(2) =13.7, P=.001). Moreover, ReMindCare patients had fewer visits to urgent care units (chi(2) =7.4, P=.006) and fewer hospitalizations than TAU patients (chi(2) =4.6, P=.03). The mean of days using the app was 352.2 (SD 191.2; min/max: 18-594), and the mean of engagement was 84.5 (SD 16.04). Conclusions: To our knowledge, this is the first eHealth intervention that has preliminarily proven its benefits in the real-world treatment of patients with early psychosis., This study was supported by the Sanitary Research Institute of the University Clinic Hospital and the Mental Health Networking Biomedical Centre. It was also supported by the Generalitat Valenciana and the Program for Scientific Research, Technological Development, and Innovation in the Generalitat Valenciana of the European Union (2017/9830). It was also supported by grants from the Generalitat Valenciana (PROMETEO/2016/082, PROMETEO/2020/024), Carlos III Health Institute (PI13/00447; PI17/00402), and European Union through the European Regional Development Fund.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

First-Episode Psychotic Patients Showed Longitudinal Brain Changes Using fMRI With an Emotional Auditory Paradigm

  • González-Vivas, Carlos
  • García-Martí, Gracián
  • Soldevila-Matías, Pau
  • Sanz-Requena, Roberto
  • Aguilar, Eduardo J.
  • Martí-Bonmatí, Luis
  • Sanjuan, Julio
  • Castro-Bleda, Maria Jose|||0000-0003-1001-8258
[EN] Most previous longitudinal studies of functional magnetic resonance imaging (fMRI) in first-episode psychosis (FEP) using cognitive paradigm task found an increased activation after antipsychotic medications. We designed an emotional auditory paradigm to explore brain activation during emotional and nonemotional word processing. This study aimed to analyze if longitudinal changes in brain fMRI BOLD activation is present in patients vs. healthy controls. A group of FEP patients (n = 34) received clinical assessment and had a fMRI scan at baseline and follow-up (average, 25-month interval). During the fMRI scan, both emotional and nonemotional words were presented as a block design. Results were compared with a pair of healthy control group (n = 13). Patients showed a decreased activation at follow-up fMRI in amygdala (F = 4.69; p = 0.04) and hippocampus (F = 5.03; p = 0.03) compared with controls. Middle frontal gyrus was the only area that showed a substantial increased activation in patients (F = 4.53; p = 0.04). A great heterogeneity in individual activation patterns was also found. These results support the relevance of the type of paradigm in neuroimaging for psychosis. This is, as far as we know, the first longitudinal study with an emotional auditory paradigm in FEP. Our results suggested that the amygdala and hippocampus play a key role in psychotic disease. More studies are needed to understand the heterogeneity of response at individual level., This study was supported by grants from the Generalitat Valenciana (PROMETEO/2016/082, PROMETEO/2020/024), CIBERSAM, and Carlos III Health Institute (PI13/00447; PI17/00402) co-funded by The European Union through FEDER funds.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Differences in the Use and Opinions About New eHealth Technologies Among Patients With Psychosis: Structured Questionnaire

  • Bonet, Lucía
  • Llácer, Blanca
  • Hernandez-Viadel, Miguel
  • Cañete, Carlos
  • Escartí, María José
  • González-Pinto, A. M.
  • Sanjuan Arias, Julio
  • Arce Grilo, Alexandre David|||0000-0003-1141-2126
  • Blanquer Espert, Ignacio|||0000-0003-1692-8922
[EN] Background: Despite a growing interest in the use of technology in order to support the treatment of psychotic disorders, limited knowledge exists about the viability and acceptability of these eHealth interventions in relation to the clinical characteristics of patients. Objective: The objective of this study was to assess the access and use of, as well as experiences and interest in, new technologies using a survey of patients diagnosed with early psychosis compared with a survey of patients diagnosed with chronic psychotic disorders. Methods: We designed a structured questionnaire. This questionnaire was divided into five parts: (1) clinical and demographic information, (2) access and use of the internet, (3) use of the internet in relation to mental health, (4) experiences with technology, and (5) patients¿ interest in eHealth services. In total, 105 patients were recruited from early psychosis units (n=65) and recovery units (n=40). Results: In this study, 84.8% (89/105) of the patients had access to the internet and 88.6% (93/105) owned an electronic internet device. In total, 71.3% (57/80) of patients who owned a mobile phone were interested in eHealth systems and 38.2% (37/97) reported negative experiences related to the internet usage. We observed differences between the groups in terms of device ownership (P=.02), the frequency of internet access (P<.001), the use of social media (P=.01), and seeking health information (P=.04); the differences were found to be higher in the early psychosis group. No differences were found between the groups in terms of the use of internet in relation to mental health, experiences and opinions about the internet, or interest in eHealth interventions (P=.43). Conclusions: The availability and use of technology for the participants in our survey were equivalent to those for the general population. The differences found between the groups in relation to the access or use of technology seemed to due to age-related factors. The use of technology involving mental health and the interest in eHealth interventions were mainly positive and equivalent between the groups. Accordingly, this group of patients is a potential target for the emerging eHealth interventions, regardless of their clinical status. However, 28.7% (23/80) of the studied patients rejected the use of internet interventions and 38.2% (37/97) had unpleasant experiences related to its usage; thus, more in-depth studies are needed to better define the profile of patients with psychosis who may benefit from eHealth treatments., This study was supported by Generalitat Valenciana (PROMETEO/2016/082 grant) and CIBERSAM and Fondo de Investigacion Sanitaria (PI01399, PI13/00447; PI17/00402, Cofunded FEDER).
Docta Complutense
Publicación Artículo científico (JournalArticle)

Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy

  • Álvarez Prats, Alejandro
  • Hernández Perera, Octavio
  • Díaz Herrera, Pilar
  • Ucero Herrería, Álvaro Conrado
  • Anabitarte Prieto, Aránzazu
  • Losada Cabrera, Antonio
  • Ortiz, Alberto
  • Rodríguez Pérez, José C.
Background Angiotensin receptor 1 blockers (ARB) are standard nephroprotective drugs in chronic kidney disease. There is less evidence for a nephroprotective effect of HMG-CoA reductase inhibitors (statins) and much less is known about potential benefits of combination therapy. We evaluated the therapeutic potential of a statin alone or in combination with an ARB in experimental chronic kidney disease. Methods Subtotally nephrectomized (5/6 Nx) rats were treated early with vehicle, losartan, cerivastatin or losartan/cerivastatin. Expression of messenger RNA (mRNA) was assessed by real-time reverse transcription–polymerase chain reaction. Tissue proteins were localized by immunohistochemistry. Nuclear factor-κB (NF-κB) activation was measured in whole kidneys. Results In contrast to the sham group, at 6 weeks, vehicle-treated 5/6 Nx rats displayed renal lesions, albuminuria and increased blood pressure, serum creatinine and total kidney NF-κB p65 DNA-binding activity and preproendothelin-1, fibronectin and type I and III collagen mRNA. NF-κB activation correlated with albuminuria and histological renal injury. Losartan or combination therapy preserved renal function, abrogated albuminuria and improved glomerular and interstitial histology. Cerivastatin alone preserved renal function and improved interstitial injury but did not influence albuminuria, glomerular histology or NF-κB activation. Losartan/cerivastatin normalized kidney NF-κB activation and extracellular matrix mRNA expression pattern. The effect of losartan alone on these parameters was less intense. All treatments decreased preproendothelin-1 mRNA and preserved interstitial capillaries. Conclusions In a chronic kidney disease model, early treatment with either an ARB or a statin preserved renal function although the mechanisms differed. Combination therapy with an ARB and a statin did not confer clear-cut advantages on biochemical and histological parameters over ARB alone, although it further improved the kidney NF-κB and gene expression profile.
Docta Complutense
Publicación Artículo científico (JournalArticle)

TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast

  • Ucero Herrería, Álvaro Conrado
  • Benito Martín, Alberto
  • Fuentes Calvo, Isabel
  • Santamaria, Beatriz
  • Blanco González, Julia
  • López Novoa, José M.
  • Ruíz Ortega, Marta
  • Egido, Jesus
  • Burkly, Linda C.
  • Martínez Salgado, Carlos
  • Ortiz, Alberto
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) regulates apoptosis, proliferation and inflammation in renal epithelial cells and plays a role in acute kidney injury. However, there is little information on the chronic effects of TWEAK. We hypothesized that TWEAK may influence renal fibrosis and regulate kidney fibroblast biology, in part, through Ras pathway. We studied a chronic model of experimental unilateral ureteral obstruction in wild type and TWEAK deficient mice, and a murine model of systemic TWEAK overexpression. TWEAK actions were also explored in cultured renal and embryonic fibroblasts. TWEAK and TWEAK receptor expression was increased in the obstructed kidneys. The absence of TWEAK decreased early kidney tubular damage, inflammatory infiltrates and myofibroblast number. TWEAK deficient mice had decreased renal fibrosis 21days after obstruction, as assessed by extracellular matrix staining. In mice without prior underlying kidney disease, systemic overexpression of TWEAK induced kidney inflammation and fibrosis. In cultured fibroblasts, TWEAK induced proliferation through activation of the Ras/ERK pathway. TWEAK also activated nuclear factor κB (NFκB)-dependent inflammatory chemokine production in murine renal fibroblasts. In conclusion, lack of TWEAK reduces renal fibrosis in a model of persistent kidney insult and overexpression of TWEAK led to renal fibrosis. TWEAK actions on renal fibroblasts may contribute to the in vivo observations, as TWEAK promotes inflammatory activity and proliferation in fibroblast cultures.
Dipòsit Digital de Documents de la UAB
Publicación Artículo preliminar (WorkingPaper)

Estate taxes, consumption externalities, and altruism

  • Alonso Carrera, Jaime|||0000-0001-8525-7769
  • Caballé, Jordi|||0000-0003-0253-5634
  • Raurich, Xavier|||0000-0002-5210-1909
We study how the introduction of consumption externalities affects the optimality of the dynamic equilibrium in an economy displaying dynastic altruism. When the bequest motive is inoperative consumption externalities affect the intertemporal margin between young and old consumption and thus modify the intertemporal path of aggregate consumption and capital. The optimal tax policy that solves this intertemporal suboptimality consists of a tax on capital income and a pay-as-you-go social security system. The latter solves the excess of capital accumulation due to the inoperativeness of the bequest motive and the former solves the suboptimal allocation of consumption due to consumption externalities. When the bequest motive is operative consumption externalities only cause an intratemporal misallocation of consumption but do not affect the optimality of the capital stock level. This suboptimal allocation of consumption implies in turn that the path of bequest deviates also from optimality. The optimal tax policy in this case consists of an estate tax and a capital income tax.
Dipòsit Digital de Documents de la UAB
Publicación Artículo preliminar (WorkingPaper)

Fiscal policy, composition of intergenerational transfers, and income distribution

  • Alonso Carrera, Jaime|||0000-0001-8525-7769
  • Caballé, Jordi|||0000-0003-0253-5634
  • Raurich, Xavier|||0000-0002-5210-1909
In this paper, we characterize the relationship between the initial distribution of human capital and physical inheritances among individuals and the long-run distribution of these two variables. In a model with indivisible investment in education, we analyze how the initial distribution of income determines the posterior intergenerational mobility in human capital and the evolution of intragenerational income inequality. This analysis enables us in turn to characterize the effects of fiscal policy on future income distribution and mobility when the composition of intergenerational transfers is endogenous. We find that a tax on inheritance results in both less intergenerational mobility and smaller investment in human capital. However, a tax on labor income may promote human capital accumulation if the education premium is sufficiently high.
Dipòsit Digital de Documents de la UAB
Publicación Artículo preliminar (WorkingPaper)

Can consumption spillovers be a source of equilibrium indeterminacy?

  • Alonso Carrera, Jaime|||0000-0001-8525-7769
  • Caballé, Jordi|||0000-0003-0253-5634
  • Raurich, Xavier|||0000-0002-5210-1909
In this paper, we show that consumption externalities are a source of equilibrium indeterminacy in a growth model with endogenous labor supply. In particular, when the marginal rate of substitution between own consumption and the others' consumption is constant along the equilibrium path, the equilibrium does not exhibit indeterminacy. In contrast, when that marginal rate of substitution is not constant, the equilibrium may exhibit indeterminacy even if the elasticity of the labor demand is smaller than the elasticity of the Frisch labor supply.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Drivers of biogenic volatile organic compound emissions in hygrophytic bryophytes

  • Yáñez Serrano, Ana María|||0000-0001-6408-5961
  • Corbera, Jordi|||0000-0003-3583-3929
  • Portillo-Estrada, Miguel|||0000-0002-0348-7446
  • Janssens, Ivan|||0000-0002-5705-1787
  • Llusia, Joan|||0000-0003-0164-2737
  • Filella, Iolanda|||0000-0001-6262-5733
  • Peñuelas, Josep|||0000-0002-7215-0150
  • Preece, Catherine|||0000-0001-6584-3541
  • Sabater i Comas, Francesc|||0000-0001-6767-231X
  • Fernández-Martínez, M.
Bryophytes can both emit and take up biogenic volatile organic compounds (BVOCs) to and from the environment. Despite the scarce study of these exchanges, BVOCs have been shown to be important for a wide range of ecological roles. Bryophytes are the most ancient clade of land plants and preserve very similar traits to those first land colonisers. Therefore, the study of these plants can help understand the early processes of BVOC emissions as an adaptation to terrestrial life. Here, we determine the emission rates of BVOCs from different bryophyte species to understand what drives such emissions. We studied 26 bryophyte species from temperate regions that can be found in mountain springs located in NE Spain. Bryophyte BVOC emission presented no significant phylogenetic signal for any of the compounds analysed. Hence, we used mixed linear models to investigate the species-specific differences and eco-physiological and environmental drivers of bryophyte BVOC emission. In general, species-specific variability was the main factor explaining bryophyte BVOC emissions; but additionally, photosynthetic rates and light intensity increased BVOC emissions. Despite emission measurements reported here were conducted at 30°, and may not directly correspond to emission rates in natural conditions, most of the screened species have never been measured before for BVOC emissions and therefore this information can help understand the drivers of the emissions of BVOCs in bryophytes.
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Cationic Carbosilane Dendritic Systems as Promising Anti-Amyloid Agents in Type 2 Diabetes

  • Lozano de la Cruz, Tania
  • Alcarraz Vizán, Gemma
  • Mata de la Mata, Francisco Javier de la|||0000-0003-0418-3935
  • Pablo, Sara de
  • Ortega Lopez, Paula|||0000-0003-0377-5429
  • Duarte, Yorley
  • Bravo Moraga, Felipe
  • González Nilo, Fernando
  • Novials, Anna
  • Gómez Ramírez, Rafael|||0000-0001-6448-2414
The most common denominator of many of the neurodegenerative diseases is badly folded protein accumulation, which results in the formation of insoluble protein deposits located in different parts of the organism, causing cell death and tissue degeneration. Dendritic systems have turned out to be a promising new therapeutic approach for the treatment of these diseases due to their ability to modulate the folding of these proteins. With this perspective, and focused on type 2 diabetes (T2D), characterized by the presence of deposits containing the amyloidogenic islet amyloid polypeptide (IAPP), we demonstrate how different topologies of cationic carbosilane dendrimers inhibit the formation of insoluble protein deposits in pancreatic islets isolated from transgenic Tg-hIAPP mice. Also, the results obtained by the modification of dendritic carbosilane wedges with the chemical chaperone 4-phenylbutyric acid (4-PBA) at the focal point confirmed their potential as anti-amyloid agents with a concentration efficiency in their therapeutic action five orders of magnitude lower than that observed for free 4-PBA. Computational studies, which determined the main interaction between IAPP and dendrimers at the atomic level, support the experimental work., Agencia Estatal de Investigación, Comunidad de Madrid, Junta de Comunidades de Castilla-La Mancha, Ministerio de Economía y Competitividad